✦ LIBER ✦

Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease

✍ Scribed by David S. Fefferman; Parag J. Lodhavia; Mazen Alsahli; Kenneth R. Falchuk; Mark A. Peppercorn; Samir A. Shah; Richard J. Farrell

Book ID: 110086221
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 77 KB
Volume: 10
Category: Article
ISSN: 1078-0998
DOI: 10.1097/00054725-200407000-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-duration response to levodopa influ

Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease

✍ Mario Zappia; Rosanna Colao; Rita Montesanti; Milena Rizzo; Umberto Aguglia; Ant 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

Protein and energy metabolism response t

Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease

✍ Steven J. Steiner; Marian D. Pfefferkorn; Joseph F. Fitzgerald; Scott C. Denne 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

## Background: Tumor necrosis factor-alpha (tnf-alpha) may contribute to the alterations in protein and energy metabolism present in children with crohn's disease (cd), who frequently suffer from growth disturbance. we hypothesized that anti-tnf-alpha therapy would reduce protein losses, due to dec

Successful induction of clinical respons

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: A real-life multicenter experience of compassionate use

✍ Silvio Danese; Filippo Mocciaro; Luisa Guidi; Maria Lia Scribano; Michele Comber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Genetic polymorphisms of tumour necrosis

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn’s disease

✍ H. MATSUKURA; S. IKEDA; N. YOSHIMURA; M. TAKAZOE; M. MURAMATSU 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Efficacy and safety of short-term adalim

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Expressions of p53 and PCNA do not corre

Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's Lymphoma

✍ Sakai, Akira; Oda, Kenji; Asaoku, Hideki; Shintaku, Sadanori; Hoshino, Shuji; Ok 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 3 views

The expression of p53 and PCNA on deparaffinized sections of tumor was assessed in relation to the International Index and response to chemotherapy. Thirty-five non-Hodgkin's lymphoma (NHL) patients were divided into three groups: aggressive NHL, mantle cell lymphoma (MCL), and low-grade NHL. None o